Sagility Expands Operational Excellence to Colombia
Sagility LLC (@sagilityhealth), a provider of technology-enabled business process management (BPM) services, announced it has extended its nearshore operational excellence to Barranquilla, Colombia. The company also runs its operations from multiple locations in Jamaica, in addition to its global capabilities in the US, Jamaica, India, and the Philippines.
Clarius and Usono Announce an International Agreement to Bring Wireless and Wearable Ultrasound Imaging to Researchers
Clarius Mobile Health (@clariusmhealth), a provider of high-definition handheld ultrasound systems, and Usono, a developer of innovative ultrasound accessories, joined forces at the ECSS Paris 2023 congress to introduce a ground-breaking wireless and wearable ultrasound imaging solution for researchers studying the anatomy of people while they move.
Abbott Receives FDA Approval for World’s First Dual-Chamber Leadless Pacemaker
Abbott (@AbbottNews) announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.
Cotiviti Introduces Prepay Claim Review Solution for Coordination of Benefits (COB) Validation
Cotiviti (@Cotiviti), a company in data-driven healthcare solutions, is expanding its end-to-end Coordination of Benefits (COB) Validation solution by adding prospective COB validation capabilities.
Dimagi Expands Global Public and Community Health Technology Across U.S.
Dimagi (@dimagi), a technology partner for public and community health, has announced an expansion of its globally-acclaimed products and services across the United States. Dimagi’s flagship product, CommCare, which has been developed and refined through 3,000+ successful global projects with international governments and NGOs, will now be widely available to support pressing and complex public and community health initiatives across the U.S.
Noyo Debuts Simpler, Faster Integration Experience for Benefits Software Platforms
Noyo (@NoyoHQ), a comapny in benefits data management, announced its new integration experience for benefits software platforms. This launch makes it easier than ever to scale real-time connectivity with insurance carriers through a single API connection.
PathogenDx’s New Rapid, Single Test Detects Salmonella and 13 Serotypes in Poultry as Foodborne Illness Remains a Significant Threat to Public Health in the US
At a time when foodborne illness remains a significant threat to public health in the US, PathogenDx (@PathogenDX), a next-generation microarray technology for better health and safety, announced the launch of SeroX, a new rapid, single test that detects Salmonella and 13 serotypes in a single shift to support the food industry’s poultry sector.
Clarify Health and Ideon Partner to Build Stronger, More Competitive Health Plan Networks
Clarify Health (@ClarifyHealth), a healthcare analytics and value-based payments platform company, announced a new partnership with Ideon, the API platform powering digital experiences in health insurance and benefits, that will enable health plans to build more competitive networks that deliver high-quality, cost-effective healthcare to members.
Introducing the Integration of MedlinePlus for Enhanced Patient Education in DocVilla
DocVilla (@PS3GInc), an Ambulatory EMR PM Software, has integrated MedlinePlus, a powerful health information resource, into their platform to provide enhanced patient education.
Making the Cut, Milestones, Accolades, Awards and More
KLAS Awards Qventus Highest Rating in First Capacity Optimization Management Report
Qventus (@qventus), a provider of AI-powered software for care operations automation, is thrilled to announce its exceptional achievement in the inaugural 2023 Capacity Optimization Management report by KLAS Research. The company has earned the highest rating in the report, solidifying its position as a leader in the industry.
Product Certification News
First drug discovered and designed with generative AI enters Phase II trials, with first patients dosed
Insilico Medicine (@InSilicoMeds), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, announced that it has completed the first dose in patients in the Phase II clinical trial of INS018_055, marking the world’s first anti-fibrotic small molecule inhibitor discovered and designed using generative AI, initiating Phase II clinical trials for further evaluation.
Med A-Z Revolutionizes Health IT with Newly ONC-Certified Product: MedAZ Complete EHR
MedAZ (@medatoz), a player in electronic health record (EHR) and practice management software, proudly announced it had received ONC Health Information Technology (ONC-HIT) CURES Act certification of their pioneering product: MedAZ Complete EHR – as of June 16, 2023 (Med A-Z 202001)*.